Companies adopting AI should measure not only efficiency gains but also whether the capacity created is being used to drive innovation and growth, Irina Ghose said.
Set as Trusted Source
on Google Search
Companies adopting AI should measure not only efficiency gains but also whether the capacity created is being used to drive innovation and growth, Irina Ghose said.
"HDFC Bank may have communicated the 2 internal candidates' names for CEO to the Reserve Bank of India," the sources informed on the condition of anonymity.
SEBI may need to weigh in as NSE eyes the "permitted to trade" window to list on rival BSE while still trading on its own platform.
The AGM was held against the backdrop of Tata Sons Chairman N Chandrasekaran deciding not to seek another term at the helm of the holding company.
Zepto plans to update its financials and then go back to market to launch its public issue, persons privy to the development said.
In an exclusive interview with NDTV Profit, Sahil Barua said nearly 100% of freight contracts are fuel-cost protected, ruling out any long-term hit to margins from elevated crude oil prices.
Emmer Capital's Raychaudhari outlined the current complex macroeconomic environment where global tech jitters, energy price spikes, and domestic inflation risks are converging to test investor resilience.
Temasek's Lambah noted that investment momentum remains strictly on track, with plans to deploy approximately $10 billion in India
Promoter holding rose from 49.52% in March to 50% at the end of June after purchases during the first quarter.
In an exclusive interview to NDTV Profit, Biocon founder, Kiran Mazumdar-Shaw, also said that insulin "will never go away" and defended company's low-margin bet.
In an exclusive interview to NDTV Profit, Kiran Mazumdar-Shaw says biology, not silicon, could solve the data centre crunch.
In an exclusive interview to NDTV Profit, Biocon founder says the CDMO arm strayed from its core strength but is now being rebuilt.
Awiqli cuts basal insulin dosing from seven injections a week to one. Novo Nordisk India MD Vikrant Shrotriya discusses price, access and growth.
The statement was issued in response to a complaint reportedly made to the Charity Commissioner regarding the transfer of Tata Sons shares that took place over three decades ago.
As part of the process, the Aditya Birla Group will conduct due diligence over the next three to four weeks before deciding on a final agreement.
The divergence in strategy comes as both companies accelerate expansion plans amid expectations that India's steel demand will continue to outpace global markets
The Bombay High Court has already disposed the petition that sought a stay on the May 16 meeting, Tata Trusts said.
Governance issues have intensified in recent months at Tata Trusts following objections related to reappointment procedures and the validity of resolutions passed by certain trusts.
While he noted the geopolitical situation has "changed the picture" and added more time to the trajectory, he remains bullish on the underlying business model.
Sources said Parekh's second term as Infosys CEO is unlikely to be followed by a full five-year extension for a third term.